- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.00 Å
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 6 residues within 4Å:- Chain C: L.105, N.135, Y.152, T.154, G.298, Q.299
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:Y.152
- Hydrogen bonds: C:Q.299
NAG-NAG.3: 6 residues within 4Å:- Chain C: T.276, H.308, N.310, N.386, T.388
- Ligands: NAG-NAG.4
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 5 residues within 4Å:- Chain C: N.274, N.310, N.386
- Ligands: NAG-NAG.3, NAG.20
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 4 residues within 4Å:- Chain C: N.241, S.270, N.421
- Ligands: NAG-NAG-BMA-MAN-MAN.6
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 6 residues within 4Å:- Chain G: L.105, N.135, Y.152, T.154, G.298, Q.299
1 PLIP interactions:1 interactions with chain G- Hydrophobic interactions: G:Y.152
NAG-NAG.9: 6 residues within 4Å:- Chain G: T.276, H.308, N.310, N.386, T.388
- Ligands: NAG-NAG.10
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 5 residues within 4Å:- Chain G: N.274, N.310, N.386
- Ligands: NAG-NAG.9, NAG.45
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 5 residues within 4Å:- Chain G: N.241, S.270, S.419, N.421
- Ligands: NAG-NAG-BMA-MAN-MAN.12
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 6 residues within 4Å:- Chain H: L.105, N.135, Y.152, T.154, G.298, Q.299
2 PLIP interactions:2 interactions with chain H- Hydrophobic interactions: H:Y.152
- Hydrogen bonds: H:Q.299
NAG-NAG.15: 6 residues within 4Å:- Chain H: T.276, H.308, N.310, N.386, T.388
- Ligands: NAG-NAG.16
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 5 residues within 4Å:- Chain H: N.274, N.310, N.386
- Ligands: NAG-NAG.15, NAG.58
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 4 residues within 4Å:- Chain H: S.270, S.419, N.421
- Ligands: NAG-NAG-BMA-MAN-MAN.18
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.6: 10 residues within 4Å:- Chain C: E.190, V.233, L.240, N.241, N.354, G.356, C.418, S.419, S.420
- Ligands: NAG-NAG.5
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:E.190, C:G.356, C:S.419
NAG-NAG-BMA-MAN-MAN.12: 11 residues within 4Å:- Chain G: E.190, P.191, V.233, L.240, N.241, N.354, G.356, C.418, S.419, S.420
- Ligands: NAG-NAG.11
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:G.356, G:S.419
NAG-NAG-BMA-MAN-MAN.18: 11 residues within 4Å:- Chain H: E.190, V.233, L.240, N.241, N.354, C.355, G.356, C.418, S.419, S.420
- Ligands: NAG-NAG.17
2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:E.190, H:S.419
- 49 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.19: 3 residues within 4Å:- Chain C: N.280, I.301, Q.415
Ligand excluded by PLIPNAG.20: 8 residues within 4Å:- Chain C: E.272, N.274, N.310, I.311, S.312, S.419
- Ligands: NAG-NAG.4, NAG-NAG.4
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain C: N.139, K.150
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain C: N.101, D.166, N.168
Ligand excluded by PLIPNAG.23: 5 residues within 4Å:- Chain C: R.171, N.176, T.177
- Chain G: S.143, H.287
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain C: N.209, T.211, F.212, N.213
Ligand excluded by PLIPNAG.25: 5 residues within 4Å:- Chain C: E.248, I.249, N.268, K.322, K.326
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain C: R.313, N.317, W.372, E.376
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain C: V.349, M.350, N.363, T.365
- Ligands: NAG.28
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain C: T.365, N.369
- Ligands: NAG.27
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain C: N.375
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain D: Q.141, Q.142, N.145
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain D: N.100
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain D: N.110, N.114
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain D: N.105, K.106
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain D: K.122, E.123, S.125, N.126
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain E: Q.141, Q.142, N.145
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain E: N.100, T.102
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain E: N.110, N.114
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain E: N.105
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain E: E.123, N.126
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain F: N.110, N.114
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain F: N.105
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain F: K.122, E.123, N.126
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain A: X.109
- Chain F: N.100
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain G: N.280, I.301, Q.415
Ligand excluded by PLIPNAG.45: 7 residues within 4Å:- Chain G: E.272, N.274, N.310, I.311, S.312
- Ligands: NAG-NAG.10, NAG-NAG.10
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain G: S.137, F.138, N.139
- Ligands: NAG.47
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain G: N.101
- Ligands: NAG.46
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain G: I.163, R.171, N.176, T.177
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain G: N.209, T.211, T.219
- Ligands: NAG.55
Ligand excluded by PLIPNAG.50: 6 residues within 4Å:- Chain G: E.248, I.249, N.268, E.269, K.322, K.326
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain G: R.313, N.317, W.372, E.376
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain G: V.349, M.350, N.363, T.365
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain G: Q.340, T.365, N.369
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain G: N.375, E.376
Ligand excluded by PLIPNAG.55: 6 residues within 4Å:- Chain G: N.213, T.215, S.253, E.254, F.256
- Ligands: NAG.49
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain G: N.255, T.257
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain H: N.280, I.301, Q.415
Ligand excluded by PLIPNAG.58: 7 residues within 4Å:- Chain H: E.272, N.274, N.310, I.311, S.312
- Ligands: NAG-NAG.16, NAG-NAG.16
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain H: S.137, F.138, N.139
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain H: N.101, T.103, N.168
Ligand excluded by PLIPNAG.61: 3 residues within 4Å:- Chain C: H.287
- Chain H: N.176, T.177
Ligand excluded by PLIPNAG.62: 5 residues within 4Å:- Chain H: N.209, T.211, F.212, N.213, T.219
Ligand excluded by PLIPNAG.63: 5 residues within 4Å:- Chain H: E.247, E.248, I.249, N.268, K.322
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain H: R.313, N.317, W.372
Ligand excluded by PLIPNAG.65: 5 residues within 4Å:- Chain H: V.349, M.350, N.363, T.365
- Ligands: NAG.66
Ligand excluded by PLIPNAG.66: 3 residues within 4Å:- Chain H: T.365, N.369
- Ligands: NAG.65
Ligand excluded by PLIPNAG.67: 2 residues within 4Å:- Chain H: N.208, N.220
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RQk-Base-A pAb heavy chain: A
RQk-Base-A pAb light chain: B
AMC016v4.2 envelope glycoprotein gp120: CGH
AMC016v4.2 transmembrane protein gp41: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AG
EH
FD
BE
CF
D
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.00 Å
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 49 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RQk-Base-A pAb heavy chain: A
RQk-Base-A pAb light chain: B
AMC016v4.2 envelope glycoprotein gp120: CGH
AMC016v4.2 transmembrane protein gp41: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AG
EH
FD
BE
CF
D